The treatment of 3xTg-AD and 5xFAD mice with IsoLiPro significantly increased the levels of SYN-1 and PSD95, as assessed by IHC staining (Fig. 6A–D) and Western blotting (Fig. 6E,F). Here, SYN1 is linked to Alzheimer disease.